← FDA DRUG APPROVALS

FDA NDA · NDA018889

METRONIDAZOLE

Sponsor: ABBOTT

APPLICATION
NDA018889
TYPE
NDA
ORIGINAL APPROVAL
1983-11-18
LATEST ACTION
1996-09-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METRONIDAZOLEDiscontinued
METRONIDAZOLE 500MG/100ML · INJECTABLE · INJECTION

Approval history

1996-09-20Manufacturing (CMC) · Supplement 11AP
1993-06-23Labeling · Supplement 10AP
1989-11-20Labeling · Supplement 9AP
1989-08-17Labeling · Supplement 8AP
1985-04-03Manufacturing (CMC) · Supplement 4AP
1984-07-24Manufacturing (CMC) · Supplement 3AP
1983-11-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →